ArticleVeterinary and animal science2026
Protective effects of nano-zinc and nano-selenium compared with a toxin binder in broiler chickens fed aflatoxin B1-contaminated diets through antioxidant, immune, and skeletal responses.
Article in Veterinary and animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aflatoxin B1 (AFB1) can impair broiler performance, redox balance, and skeletal health. This 42-day study evaluated whether partial replacement of conventional inorganic zinc (Zn) and selenium (Se) sources with nanoforms could mitigate AFB1-associated responses and compared this source-substitution strategy with the use of commercial toxin binder. A total of 792 day-old male Ross 308 broilers were allocated to six treatments (6 replicate pens/treatment, 22 birds/pen; pen served as the experimental unit): Control; AF (0.5 mg AFB1/kg); AF+TB (2 g toxin binder/kg); AF+NZ (40 mg Zn/kg supplied as nano-zinc in place of an equivalent amount from zinc sulfate); AF+NS (0.1 mg Se/kg supplied as nano-selenium in place of an equivalent amount from sodium selenite); and AF+NZ+NS (combined nano-Zn and nano-Se partial replacement). Supplemental Zn and Se were maintained at 120 and 0.3 mg/kg, respectively. Relative to AF, AF+TB and AF+NZ+NS increased body weight gain by 9.7% and 6.3%, feed efficiency by 6.8% and 5.7%, total antioxidant capacity by 37.6% and 34.5%, and serum GSH by 38.6% and 35.7%, respectively, while reducing serum MDA by 31.0% and 32.1% (P < 0.05). Both treatments also improved selected immunoglobulin measures, hepatic expression of NFE2L2, GPX1, and SOD1, culture-based bacterial counts, tibial length and tibia ash content, although AF+NZ+NS did not consistently outperform the single nano-mineral treatments and did not fully restore the control phenotype. Under the conditions of this 42-day, 0.5 mg/kg AFB1 challenge, combined partial replacement with nano-Zn and nano-Se improved several measured responses, including productive performance, antioxidant status, and tibia quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.